ZOLAR is a first-in-human, proof-of-concept and biodistribution trial that uses positron emission tomography (PET) to evaluate olaratumab, a monoclonal antibody, as a therapeutic radiopharmaceutical ...
Zero Candida Technologies, Inc. (TSXV: ZCT) (OTCQB: ZCTFF) (FSE: 9L2) (the "Company" or "ZCT"), a FemTech medical device ...
Through exclusive research interviews with senior private banking leaders, Euromoney undercovers four tectonic shifts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback